Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
1.
Cell ; 147(2): 332-43, 2011 Oct 14.
Article in English | MEDLINE | ID: mdl-21982154

ABSTRACT

The immunoglobulin heavy-chain (IgH) gene locus undergoes radial repositioning within the nucleus and locus contraction in preparation for gene recombination. We demonstrate that IgH locus conformation involves two levels of chromosomal compaction. At the first level, the locus folds into several multilooped domains. One such domain at the 3' end of the locus requires an enhancer, Eµ; two other domains at the 5' end are Eµ independent. At the second level, these domains are brought into spatial proximity by Eµ-dependent interactions with specific sites within the V(H) region. Eµ is also required for radial repositioning of IgH alleles, indicating its essential role in large-scale chromosomal movements in developing lymphocytes. Our observations provide a comprehensive view of the conformation of IgH alleles in pro-B cells and the mechanisms by which it is established.


Subject(s)
B-Lymphocytes/metabolism , Cell Nucleus/genetics , Chromatin/chemistry , Genes, Immunoglobulin Heavy Chain , Immunoglobulin Heavy Chains/genetics , Animals , CCCTC-Binding Factor , Enhancer Elements, Genetic , Immunoglobulin Variable Region , Mice , Mice, 129 Strain , Mice, Inbred C57BL , Repressor Proteins/metabolism , V(D)J Recombination , YY1 Transcription Factor/metabolism
2.
PLoS Biol ; 11(1): e1001475, 2013.
Article in English | MEDLINE | ID: mdl-23382652

ABSTRACT

Multiple epigenetic marks have been proposed to contribute to the regulation of antigen receptor gene assembly via V(D)J recombination. Here we provide a comprehensive view of DNA methylation at the immunoglobulin heavy chain (IgH) gene locus prior to and during V(D)J recombination. DNA methylation did not correlate with the histone modification state on unrearranged alleles, indicating that these epigenetic marks were regulated independently. Instead, pockets of tissue-specific demethylation were restricted to DNase I hypersensitive sites within this locus. Though unrearranged diversity (D(H)) and joining (J(H)) gene segments were methylated, DJ(H) junctions created after the first recombination step were largely demethylated in pro-, pre-, and mature B cells. Junctional demethylation was highly localized, B-lineage-specific, and required an intact tissue-specific enhancer, Eµ. We propose that demethylation occurs after the first recombination step and may mark the junction for secondary recombination.


Subject(s)
DNA Methylation , Gene Rearrangement, B-Lymphocyte, Heavy Chain , Immunoglobulin Heavy Chains/genetics , Immunoglobulin Variable Region/genetics , V(D)J Recombination , Animals , B-Lymphocytes/immunology , CpG Islands/genetics , DNA-Binding Proteins/genetics , Deoxyribonuclease I , Enhancer Elements, Genetic , Genes, Immunoglobulin Heavy Chain , Histones/genetics , Histones/metabolism , Mice , Mice, Inbred C57BL , Mice, Knockout , Regulatory Sequences, Nucleic Acid , T-Lymphocytes/immunology
3.
EMBO J ; 30(6): 1040-53, 2011 Mar 16.
Article in English | MEDLINE | ID: mdl-21317874

ABSTRACT

Ionizing radiation (IR) triggers adaptive changes in gene expression. Here, we show that survival after IR strongly depends on the checkpoint kinase Chk2 acting upon its substrate HuR, an RNA-binding protein that stabilizes and/or modulates the translation of target mRNAs. Microarray analysis showed that in human HCT116 colorectal carcinoma cells (WT), IR-activated Chk2 triggered the dissociation of virtually all of HuR-bound mRNAs, since IR did not dissociate HuR target mRNAs in Chk2-null (CHK2-/-) HCT116 cells. Accordingly, several HuR-interacting mRNAs encoding apoptosis- and proliferation-related proteins (TJP1, Mdm2, TP53BP2, Bax, K-Ras) dissociated from HuR in WT cells, but remained bound and showed altered post-transcriptional regulation in CHK2-/- cells. Use of HuR mutants that were not phosphorylatable by Chk2 (HuR(3A)) and HuR mutants mimicking constitutive phosphorylation by Chk2 (HuR(3D)) revealed that dissociation of HuR target transcripts enhanced cell survival. We propose that the release of HuR-bound mRNAs via an IR-Chk2-HuR regulatory axis improves cell outcome following IR.


Subject(s)
Antigens, Surface/metabolism , Epithelial Cells/radiation effects , Gene Expression Regulation , Protein Serine-Threonine Kinases/metabolism , RNA, Messenger/metabolism , RNA-Binding Proteins/metabolism , Radiation, Ionizing , Antigens, Surface/genetics , Cell Line , Cell Survival , Checkpoint Kinase 2 , ELAV Proteins , ELAV-Like Protein 1 , Gene Knockout Techniques , Humans , RNA-Binding Proteins/genetics
4.
Nucleic Acids Res ; 39(19): 8513-30, 2011 Oct.
Article in English | MEDLINE | ID: mdl-21737422

ABSTRACT

RNA-binding proteins (RBPs) regulate gene expression at many post-transcriptional levels, including mRNA stability and translation. The RBP nucleolin, with four RNA-recognition motifs, has been implicated in cell proliferation, carcinogenesis and viral infection. However, the subset of nucleolin target mRNAs and the influence of nucleolin on their expression had not been studied at a transcriptome-wide level. Here, we globally identified nucleolin target transcripts, many of which encoded cell growth- and cancer-related proteins, and used them to find a signature motif on nucleolin target mRNAs. Surprisingly, this motif was very rich in G residues and was not only found in the 3'-untranslated region (UTR), but also in the coding region (CR) and 5'-UTR. Nucleolin enhanced the translation of mRNAs bearing the G-rich motif, since silencing nucleolin did not change target mRNA stability, but decreased the size of polysomes forming on target transcripts and lowered the abundance of the encoded proteins. In summary, nucleolin binds G-rich sequences in the CR and UTRs of target mRNAs, many of which encode cancer proteins, and enhances their translation.


Subject(s)
Phosphoproteins/metabolism , Protein Biosynthesis , RNA, Messenger/metabolism , RNA-Binding Proteins/metabolism , Genes, Reporter , Guanine/analysis , HeLa Cells , Humans , Neoplasm Proteins/genetics , Nucleotide Motifs , RNA Stability , RNA, Messenger/chemistry , Transcriptome , Untranslated Regions , Nucleolin
5.
Aging Cell ; 12(5): 890-900, 2013 Oct.
Article in English | MEDLINE | ID: mdl-23758631

ABSTRACT

Noncoding RNAs include small transcripts, such as microRNAs and piwi-interacting RNAs, and a wide range of long noncoding RNAs (lncRNAs). Although many lncRNAs have been identified, only a small number of lncRNAs have been characterized functionally. Here, we sought to identify lncRNAs differentially expressed during replicative senescence. We compared lncRNAs expressed in proliferating, early-passage, 'young' human diploid WI-38 fibroblasts [population doubling (PDL) 20] with those expressed in senescent, late-passage, 'old' fibroblasts (PDL 52) by RNA sequencing (RNA-Seq). Numerous transcripts in all lncRNA groups (antisense lncRNAs, pseudogene-encoded lncRNAs, previously described lncRNAs and novel lncRNAs) were validated using reverse transcription (RT) and real-time, quantitative (q)PCR. Among the novel senescence-associated lncRNAs (SAL-RNAs) showing lower abundance in senescent cells, SAL-RNA1 (XLOC_023166) was found to delay senescence, because reducing SAL-RNA1 levels enhanced the appearance of phenotypic traits of senescence, including an enlarged morphology, positive ß-galactosidase activity, and heightened p53 levels. Our results reveal that the expression of known and novel lncRNAs changes with senescence and suggests that SAL-RNAs play direct regulatory roles in this important cellular process.


Subject(s)
Aging/genetics , RNA, Long Noncoding/genetics , Cell Growth Processes/genetics , Fibroblasts/cytology , Fibroblasts/metabolism , Fibroblasts/physiology , Gene Expression Regulation , Humans , Pseudogenes , RNA, Antisense/biosynthesis , RNA, Antisense/genetics , RNA, Long Noncoding/biosynthesis , Transcriptome , Transfection
6.
PLoS One ; 6(6): e20639, 2011.
Article in English | MEDLINE | ID: mdl-21673984

ABSTRACT

T cell development occurs in the thymus and is critically dependent on productive TCRß rearrangement and pre-TCR expression in DN3 cells. The requirement for pre-TCR expression results in the arrest of thymocytes at the DN3 stage (ß checkpoint), which is uniquely permissive for V-DJß recombination; only cells expressing pre-TCR survive and develop beyond the DN3 stage. In addition, the requirement for TCRß rearrangement and pre-TCR expression enforces suppression of TCRß rearrangement on a second allele, allelic exclusion, thus ensuring that each T cell expresses only a single TCRß product. However, it is not known whether pre-TCR expression is essential for allelic exclusion or alternatively if allelic exclusion is enforced by developmental changes that can occur in the absence of pre-TCR. We asked if thymocytes that were differentiated without pre-TCR expression, and therefore without pause at the ß checkpoint, would suppress all V-DJß rearrangement. We previously reported that premature CD28 signaling in murine CD4(-)CD8(-) (DN) thymocytes supports differentiation of CD4(+)CD8(+) (DP) cells in the absence of pre-TCR expression. The present study uses this model to define requirements for TCRß rearrangement and allelic exclusion. We demonstrate that if cells exit the DN3 developmental stage before TCRß rearrangement occurs, V-DJß rearrangement never occurs, even in DP cells that are permissive for D-Jß and TCRα rearrangement. These results demonstrate that pre-TCR expression is not essential for thymic differentiation to DP cells or for V-DJß suppression. However, the requirement for pre-TCR signals and the exclusion of alternative stimuli such as CD28 enforce a developmental "pause" in early DN3 cells that is essential for productive TCRß rearrangement to occur.


Subject(s)
Cell Differentiation , Gene Rearrangement, beta-Chain T-Cell Antigen Receptor , Membrane Glycoproteins/genetics , Membrane Glycoproteins/metabolism , Receptors, Antigen, T-Cell, alpha-beta/genetics , Receptors, Antigen, T-Cell, alpha-beta/metabolism , Thymus Gland/cytology , Animals , B7-2 Antigen/genetics , B7-2 Antigen/metabolism , CD28 Antigens/genetics , CD28 Antigens/metabolism , DNA-Binding Proteins/metabolism , Gene Expression Regulation/immunology , Gene Rearrangement, alpha-Chain T-Cell Antigen Receptor , Histones/chemistry , Histones/metabolism , Lysine , Methylation , Mice , Mice, Transgenic , T-Lymphocytes/cytology , T-Lymphocytes/immunology , T-Lymphocytes/metabolism , Thymus Gland/metabolism , Transcription, Genetic/immunology
7.
Mol Cell Biol ; 31(4): 626-38, 2011 Feb.
Article in English | MEDLINE | ID: mdl-21135128

ABSTRACT

Adipose tissue development is tightly regulated by altering gene expression. MicroRNAs are strong posttranscriptional regulators of mammalian differentiation. We hypothesized that microRNAs might influence human adipogenesis by targeting specific adipogenic factors. We identified microRNAs that showed varying abundance during the differentiation of human preadipocytes into adipocytes. Among them, miR-130 strongly affected adipocyte differentiation, as overexpressing miR-130 impaired adipogenesis and reducing miR-130 enhanced adipogenesis. A key effector of miR-130 actions was the protein peroxisome proliferator-activated receptor γ (PPARγ), a major regulator of adipogenesis. Interestingly, miR-130 potently repressed PPARγ expression by targeting both the PPARγ mRNA coding and 3' untranslated regions. Adipose tissue from obese women contained significantly lower miR-130 and higher PPARγ mRNA levels than that from nonobese women. Our findings reveal that miR-130 reduces adipogenesis by repressing PPARγ biosynthesis and suggest that perturbations in this regulation is linked to human obesity.


Subject(s)
Adipogenesis/genetics , Adipogenesis/physiology , MicroRNAs/genetics , MicroRNAs/metabolism , PPAR gamma/genetics , PPAR gamma/metabolism , 3T3-L1 Cells , Adipocytes/cytology , Adipocytes/metabolism , Adult Stem Cells/cytology , Adult Stem Cells/metabolism , Animals , Base Sequence , Cell Differentiation/genetics , Cell Differentiation/physiology , DNA Primers/genetics , Female , Gene Expression Regulation, Developmental , Humans , In Vitro Techniques , Mice , Obesity/genetics , Obesity/metabolism , RNA, Messenger/genetics , RNA, Messenger/metabolism , Species Specificity , Thinness/genetics , Thinness/metabolism
8.
Mol Reprod Dev ; 75(1): 1-7, 2008 Jan.
Article in English | MEDLINE | ID: mdl-17492761

ABSTRACT

Placental oestrogens play an important role as local regulators of placental growth and differentiation during gestation, and toward term they are also involved in the preparation of parturition. They are synthesized within the fetal cotyledons of placentomes by aromatase cytochrome P450 (P450arom; EC 1.14.14.1), the product of the Cyp 19 gene. The first step of regulation of P450arom expression, and hence enzyme activity and oestrogen production, takes place at the level of Cyp 19 transcription, which is driven by a proximal promoter region, P1.5/2, in the sheep placenta. The aim of the present study was to find out if different Cyp 19 expression levels, which previously had been observed in ovine placentome tissues, correlate with the tissue-specific chromatin structure of the promoter. To this end, we investigated the chromatin structure across the P1.5/2 region in caruncles and cotyledons from 100 and 125 days pregnant ewes, and in term placentae, respectively, by analyzing the DNA methylation and the accessibility to restriction digestion. Our data show that: (1) cotyledonal DNA was significantly lower methylated than caruncular DNA; (2) methylation of cotyledonal DNA was low at 100 and 125 days of pregnancy, and increased to a significant higher level in term placentae; and (3) concurrently, cotyledonal chromatin became inaccessible to restriction digestion at term of gestation. The results imply that DNA methylation and chromatin accessibility of the P1.5/2 promoter region correlate with expression levels of the Cyp 19 gene.


Subject(s)
Aromatase/genetics , Chromatin/chemistry , DNA Methylation , Gene Expression Regulation, Developmental , Placenta/enzymology , Sheep, Domestic/genetics , Animals , Female , Pregnancy , Promoter Regions, Genetic , Sheep, Domestic/embryology , Sheep, Domestic/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL